Connect Biopharma Holdings Limited
CNTB
$2.65
-$0.01-0.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.00K | 48.00K | -- | 958.50K | 1.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.00K | 48.00K | -- | 958.50K | 1.22M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 16.00K | 48.00K | -- | 958.50K | 1.22M |
| SG&A Expenses | 6.58M | 4.70M | 4.81M | 5.90M | 4.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | 1.29M | -- |
| Total Operating Expenses | 17.69M | 13.47M | 11.45M | 15.16M | 13.27M |
| Operating Income | -17.68M | -13.42M | -11.45M | -14.20M | -12.05M |
| Income Before Tax | -17.14M | -12.84M | -10.22M | -11.56M | -12.82M |
| Income Tax Expenses | 61.00K | 55.00K | 54.00K | 81.50K | 57.00K |
| Earnings from Continuing Operations | -17.20M | -12.90M | -10.27M | -11.64M | -12.88M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.20M | -12.90M | -10.27M | -11.64M | -12.88M |
| EBIT | -17.68M | -13.42M | -11.45M | -14.20M | -12.05M |
| EBITDA | -17.50M | -13.25M | -11.27M | -14.04M | -11.87M |
| EPS Basic | -0.31 | -0.23 | -0.19 | -0.21 | -0.23 |
| Normalized Basic EPS | -0.19 | -0.14 | -0.12 | -0.14 | -0.12 |
| EPS Diluted | -0.31 | -0.23 | -0.19 | -0.21 | -0.23 |
| Normalized Diluted EPS | -0.19 | -0.14 | -0.12 | -0.14 | -0.12 |
| Average Basic Shares Outstanding | 55.72M | 55.50M | 55.35M | 55.28M | 55.25M |
| Average Diluted Shares Outstanding | 55.72M | 55.50M | 55.35M | 55.28M | 55.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |